Top Page | English | 简体中文 | 繁體中文 | 한국어 | 日本語
Monday, 23 January 2012, 09:00 HKT/SGT
Share:
    

Source: Pharma Regulatory Affairs
National Agency of Drug and Food Control, Indonesia Newly Confirmed Present at 2nd Annual Pharma Regulatory Affairs Asia

SINGAPORE, Jan 23, 2012 - (ACN Newswire) - "Asia regulations keep on changing, in particular in all the established countries like China and Japan. Another change is that many countries don't have regulations at the moment but they are going to have new regulations (e.g. drug-medical device combined product) coming, so they will uniquely register in their country very soon. In the past, you didn't need it. An example of this is India, Hong Kong, Singapore, Malaysia, etc. So there will be two major dynamics that I think companies need to be aware of," said Jack Wong, Regulatory Affairs Director, Johnson and Johnson Medical.

Indeed, like what Jack has mentioned, ensuring regulatory compliance has become one of the biggest challenges for products development in Asia.

Jack Wong will be speaking at the 2nd Annual Pharma Regulatory Affairs Asia conference, which will take place on 25-26 April 2012 in Singapore.

In China, what's the impact of the healthcare system reform on pharma companies?

In Korea, what's the impact of recently IND Regulation changes and what's the next step of regulation updates?

In Vietnam, what is the regulation framework for drug registration and product commercialisation?

In Indonesia, what are the new regulations related to pre-market evaluation?

The 2nd Annual Pharma Regulatory Affairs Asia conference will feature speakers from Thailand FDA, National Agency of Drug and Food Control, Indonesia, DIA, APEC Harmonization Centre, Novartis, AstraZeneca, Johnson & Johnson among the others, and will discuss pharma regulation updates and regulatory compliance in China, India, Korea, Thailand, Vietnam, Indonesia and Philippines.

Drop an email to enquiry@iqpc.com.sg to register for the conference or visit www.pharmaregulatoryaffairsasia.com for the full list of speakers and topics that will be covered at the 2nd Annual Pharma Regulatory Affairs Asia.


Contact:
Bryan Camoens
IQPC Worldwide
Tel: +65-67229406
Email: bryan.camoens@iqpc.com.sg


Topic: Press release summary
Source: Pharma Regulatory Affairs

Sectors: Trade Shows, BioTech
http://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2025 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.



Latest Press Releases
Graid Technology Unveils SupremeRAID(TM) AE: The AI Edition Designed for GPU-Driven AI Workloads  
Jan 8, 2025 13:00 HKT/SGT
Honda and Renesas Sign Agreement to Develop High-Performance SoC for Software-Defined Vehicles  
Wednesday, January 8, 2025 11:30:00 AM
The Quantum Revolution. How Quantum Computing Will Transform the Global Economy in the Next Decade  
Jan 8, 2025 08:30 HKT/SGT
Stableton Partners with Alta to Expand Access to Global High-Growth Pre-IPO Investments  
Jan 8, 2025 00:02 HKT/SGT
Asian Financial Forum held next week as the region's first major international financial assembly of 2025  
Jan 7, 2025 22:33 HKT/SGT
Mitsubishi Motors to Display Custom Versions of the Triton at Tokyo Auto Salon 2025  
Tuesday, January 7, 2025 2:41:00 PM
CleverTap Predicts Key Trends for Customer Engagement in 2025  
Jan 7, 2025 14:30 HKT/SGT
'Toyota Woven City,' a Test Course for Mobility, Completes Phase 1 Construction and Prepares for Launch  
Tuesday, January 7, 2025 2:25:00 PM
$INDX Token Pre-Sale Kicks Off as CryptoIndex.com Paves the Way for Decentralized Indexing  
Jan 7, 2025 12:00 HKT/SGT
Elucidation of part of the Mechanism by which Lecanemab Slows the Progression of Alzheimer's Disease  
Tuesday, January 7, 2025 8:14:00 AM
More Press release >>
 Events:
More >>
 News Alerts
Copyright © 2025 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: